191 related articles for article (PubMed ID: 30291912)
1. 11β-hydroxysteroid dehydrogenase type 1 inhibitor attenuates high-fat diet induced cardiomyopathy.
Huang M; Liu J; Sheng Y; Lv Y; Yu J; Qi H; Di W; Lv S; Zhou S; Ding G
J Mol Cell Cardiol; 2018 Dec; 125():106-116. PubMed ID: 30291912
[TBL] [Abstract][Full Text] [Related]
2. 11beta-hydroxysteroid dehydrogenase type 1 deficiency prevents memory deficits with aging by switching from glucocorticoid receptor to mineralocorticoid receptor-mediated cognitive control.
Yau JL; Noble J; Seckl JR
J Neurosci; 2011 Mar; 31(11):4188-93. PubMed ID: 21411659
[TBL] [Abstract][Full Text] [Related]
3. 11β-Hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction.
Wu L; Qi H; Zhong Y; Lv S; Yu J; Liu J; Wang L; Bi J; Kong X; Di W; Zha J; Liu F; Ding G
Endocr J; 2013; 60(9):1047-58. PubMed ID: 23759754
[TBL] [Abstract][Full Text] [Related]
4. BVT.2733, a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, attenuates obesity and inflammation in diet-induced obese mice.
Wang L; Liu J; Zhang A; Cheng P; Zhang X; Lv S; Wu L; Yu J; Di W; Zha J; Kong X; Qi H; Zhong Y; Ding G
PLoS One; 2012; 7(7):e40056. PubMed ID: 22768329
[TBL] [Abstract][Full Text] [Related]
5. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.
Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE
Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological evaluation of adipose dysfunction via 11β-hydroxysteroid dehydrogenase type 1 in the development of diabetes in diet-induced obese mice with cortisone pellet implantation.
Akiyama N; Akiyama Y; Kato H; Kuroda T; Ono T; Imagawa K; Asakura K; Shinosaki T; Murayama T; Hanasaki K
J Pharmacol Exp Ther; 2014 Apr; 349(1):66-74. PubMed ID: 24511146
[TBL] [Abstract][Full Text] [Related]
7. Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Attenuates High-Fat Diet-Induced Hepatic Steatosis in Mice.
Li H; Sheng J; Wang J; Gao H; Yu J; Ding G; Ding N; He W; Zha J
Drug Des Devel Ther; 2021; 15():2309-2324. PubMed ID: 34103895
[TBL] [Abstract][Full Text] [Related]
8. The Aldosterone Receptor Antagonist Eplerenone Inhibits Isoproterenol-Induced Collagen-I and 11β-HSD1 Expression in Rat Cardiac Fibroblasts and the Left Ventricle.
Hori Y; Touei D; Saitoh R; Yamagishi M; Kanai K; Hoshi F; Itoh N
Biol Pharm Bull; 2017; 40(10):1716-1723. PubMed ID: 28966243
[TBL] [Abstract][Full Text] [Related]
9. Contribution of glucocorticoid-mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction.
Hirata A; Maeda N; Nakatsuji H; Hiuge-Shimizu A; Okada T; Funahashi T; Shimomura I
Biochem Biophys Res Commun; 2012 Mar; 419(2):182-7. PubMed ID: 22326264
[TBL] [Abstract][Full Text] [Related]
10. Increased glucocorticoid receptor and 11{beta}-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice.
Liu Y; Nakagawa Y; Wang Y; Sakurai R; Tripathi PV; Lutfy K; Friedman TC
Diabetes; 2005 Jan; 54(1):32-40. PubMed ID: 15616008
[TBL] [Abstract][Full Text] [Related]
11. Essential roles of 11β-HSD1 in regulating brown adipocyte function.
Liu J; Kong X; Wang L; Qi H; Di W; Zhang X; Wu L; Chen X; Yu J; Zha J; Lv S; Zhang A; Cheng P; Hu M; Li Y; Bi J; Li Y; Hu F; Zhong Y; Xu Y; Ding G
J Mol Endocrinol; 2013 Feb; 50(1):103-13. PubMed ID: 23197361
[TBL] [Abstract][Full Text] [Related]
12. A novel role for the mineralocorticoid receptor in glucocorticoid driven vascular calcification.
Zhu D; Rashdan NA; Chapman KE; Hadoke PW; MacRae VE
Vascul Pharmacol; 2016 Nov; 86():87-93. PubMed ID: 27153999
[TBL] [Abstract][Full Text] [Related]
13. Curcumin as a potent and selective inhibitor of 11β-hydroxysteroid dehydrogenase 1: improving lipid profiles in high-fat-diet-treated rats.
Hu GX; Lin H; Lian QQ; Zhou SH; Guo J; Zhou HY; Chu Y; Ge RS
PLoS One; 2013; 8(3):e49976. PubMed ID: 23533564
[TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid and glucocorticoid receptors differentially regulate NF-kappaB activity and pro-inflammatory cytokine production in murine BV-2 microglial cells.
Chantong B; Kratschmar DV; Nashev LG; Balazs Z; Odermatt A
J Neuroinflammation; 2012 Nov; 9():260. PubMed ID: 23190711
[TBL] [Abstract][Full Text] [Related]
15. Contribution of mineralocorticoid and glucocorticoid receptors to the chronotropic and hypertrophic actions of aldosterone in neonatal rat ventricular myocytes.
Rossier MF; Python M; Maturana AD
Endocrinology; 2010 Jun; 151(6):2777-87. PubMed ID: 20392829
[TBL] [Abstract][Full Text] [Related]
16. Contribution of endogenous glucocorticoids and their intravascular metabolism by 11β-HSDs to postangioplasty neointimal proliferation in mice.
Iqbal J; Macdonald LJ; Low L; Seckl JR; Yau CW; Walker BR; Hadoke PW
Endocrinology; 2012 Dec; 153(12):5896-905. PubMed ID: 23125311
[TBL] [Abstract][Full Text] [Related]
17. Expression of mineralocorticoid and glucocorticoid receptors in preautonomic neurons of the rat paraventricular nucleus.
Chen J; Gomez-Sanchez CE; Penman A; May PJ; Gomez-Sanchez E
Am J Physiol Regul Integr Comp Physiol; 2014 Mar; 306(5):R328-40. PubMed ID: 24381176
[TBL] [Abstract][Full Text] [Related]
18. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of 11β-hydroxysteroid dehydrogenase type 1 ameliorates obesity-related insulin resistance.
Shao S; Zhang X; Zhang M
Biochem Biophys Res Commun; 2016 Sep; 478(1):474-480. PubMed ID: 27268236
[TBL] [Abstract][Full Text] [Related]
20. Optimal elevation of β-cell 11β-hydroxysteroid dehydrogenase type 1 is a compensatory mechanism that prevents high-fat diet-induced β-cell failure.
Turban S; Liu X; Ramage L; Webster SP; Walker BR; Dunbar DR; Mullins JJ; Seckl JR; Morton NM
Diabetes; 2012 Mar; 61(3):642-52. PubMed ID: 22315313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
